Cleerly

About:

Cleerly is a digital healthcare company that offers heart disease diagnosis solutions.

Website: https://cleerlyhealth.com/

Twitter/X: Cleerlyhealth

Top Investors: Novartis, Fidelity, Sands Capital Ventures, T. Rowe Price, Mirae Asset Capital

Description:

Cleerly is a healthcare company whose mission is to create digital care pathways to prevent heart attacks. The company develops a new standard for coronary artery disease by integrating quality clinical science with the latest-generation AI, in order to offer actionable clinical insights to every stakeholder in the heart care pathway. Through these data-driven solutions, the company aims to provide a comprehensive solution for cardiovascular disease evaluation that offers value to the healthcare system and improves heart health for patients at risk of heart attacks.

Total Funding Amount:

$280M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

New York, New York, United States

Founded Date:

2017-01-01

Contact Email:

info(AT)cleerlyhealth.com

Founders:

James K. Min

Number of Employees:

101-250

Last Funding Date:

2022-07-25

IPO Status:

Private

© 2024 MyAiNote.com